Development of global & local clinical, economic, HCRU, and QoL SLRs in preparation for HTA submissions

Global Value Dossier, HTA tracker & Objection Handler

Nordic, UK and EU Access & HTA Submissions

Overturning a negative reimbursement decision in Norway

Development of Global CEM and BIM for immuno-oncology combination treatment within an oncology indication

Identification and quantification of value blocks for early pipeline assets

A roadmap of innovative market access approaches in the Nordics